Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

137.90 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,379
Open 137.90
Bid (Size) 137.15 (1)
Ask (Size) 137.60 (1)
Prev. Close 137.90
Today's Range 137.90 - 137.90
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The RBA Kept Interest Rates On Hold And Remained Hawkish
The Reserve Bank of Australia kept the cash rate at 4.35% at its June meeting, leaving borrowing costs unchanged for the fifth time. 
Via Talk Markets
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
OpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support physicians in creating personalized cancer care plans, emphasizing the tool's role in augmenting rather than... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+22.58%
+22.58%
1 Month
-2.21%
-2.21%
3 Month
+32.27%
+32.27%
6 Month
+61.44%
+61.44%
1 Year
+11.00%
+11.00%

More News

Read More
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
Via MarketBeat
Exposures COVID-19
Moderna Just Gave Investors Another Reason to Buy the Stock
Via The Motley Fool
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
Via ACCESSWIRE
Smart Money Is Betting Big In MRNA Options
Via Benzinga
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Via ACCESSWIRE
7 Struggling Stocks to Sell Before July 2024
Via InvestorPlace
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
Via InvestorPlace
Exposures Product Safety
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
What's Going On With Moderna Stock Monday?
Via Benzinga
Exposures COVID-19
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
Via Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Via Investor's Business Daily
Exposures COVID-19
Why Moderna Stock Is a No-Brainer Buy Right Now
Via The Motley Fool
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Via ACCESSWIRE
3 Reasons to Buy Moderna Stock
Via The Motley Fool
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Via Benzinga
Exposures COVID-19 Product Safety
5 Stocks Propelling S&P 500 To 25th Record High
Via Talk Markets
Topics Stocks
Exposures US Equities
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Via AB Newswire
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Via Benzinga
Novavax Stock’s Recent Surge and Future Potential
Via MarketBeat
Topics Economy
Exposures COVID-19 Product Safety Supply Chain
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
Via Benzinga
Exposures Product Safety
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
Via InvestorPlace
Exposures COVID-19
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns
Via AB Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.